China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
01 1Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.
02 1Nortec Quimica S.A.
03 1BENECHIM
04 1Apex Healthcare Limited
05 1DARMERICA, LLC
06 1Fagron Inc
07 1Galenova Inc
08 1KALCHEM INTERNATIONAL INC
09 1LETCO MEDICAL, LLC
10 1Medisca Inc.
11 1Professional Compounding Centers of America
12 2Professional Compounding Centers of America dba PCCA
13 1Siegfried Evionnaz SA
14 1Spectrum Laboratory Products, Inc.
15 1Swati Spentose Private Limited
01 1PRILOCAINE
02 5PRILOCAINE HYDROCHLORIDE
03 2Prilocaine HCl
04 8Prilocaine Hydrochloride
01 1Brazil
02 1Canada
03 1China
04 2India
05 1Netherlands
06 1Spain
07 1Switzerland
08 5U.S.A
09 3United Kingdom
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
NDC Package Code : 82481-016
Start Marketing Date : 2022-01-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Nortec Quimica is the largest API manufacturer in Latin America.
NDC Package Code : 59014-0051
Start Marketing Date : 2017-04-03
End Marketing Date : 2025-09-30
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 53335-0002
Start Marketing Date : 2012-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1535
Start Marketing Date : 2017-03-30
End Marketing Date : 2025-09-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0155
Start Marketing Date : 2014-06-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0338
Start Marketing Date : 2024-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0101
Start Marketing Date : 2019-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0210
Start Marketing Date : 2021-08-06
End Marketing Date : 2025-09-30
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17381-249
Start Marketing Date : 2010-04-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-6010
Start Marketing Date : 1990-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Citanest manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citanest, including repackagers and relabelers. The FDA regulates Citanest manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citanest API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Citanest manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Citanest supplier is an individual or a company that provides Citanest active pharmaceutical ingredient (API) or Citanest finished formulations upon request. The Citanest suppliers may include Citanest API manufacturers, exporters, distributors and traders.
click here to find a list of Citanest suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Citanest as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Citanest API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Citanest as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Citanest and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Citanest NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Citanest suppliers with NDC on PharmaCompass.
We have 14 companies offering Citanest
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
